An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

New research led by a St. Michael's Hospital clinician-scientist and published in the New England Journal of Medicine ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on ...

Dr. Alberto Ascherio of Harvard and Dr. Stephen Hauser of the University of California, San Francisco (UCSF) — will share $3 ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with ...

UK researchers have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatment ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, ...

Magnetic Resonance Imaging (MRI) markers are crucial for studying and testing treatments for MS. However, measuring these markers needs different types of specialised MRI scans, limiting the ...